Aura Biosciences, Inc. AURA Current ratio

Current ratio at other companies

Johnson & JohnsonJNJ

1.1×+0.1×

Merck & Co.MRK

1.3×-0.1×

ImmunityBio, Inc.IBRX

6.7×+4.4×

UroGen PharmaURGN

3.8×-0.3×

IDEAYA Biosciences, Inc.IDYA

10.7×-3.2×

CG OncologyCGON

22.2×+0.1×

FAQ

What is Aura Biosciences, Inc.'s current ratio?

Aura Biosciences, Inc. (AURA) reported current ratio of 7.1× in Q1 2026.

How has Aura Biosciences, Inc.'s current ratio changed year-over-year?

Aura Biosciences, Inc.'s current ratio decreased by 35.9% year-over-year, from 11.1× to 7.1×.

What is the long-term trend for Aura Biosciences, Inc.'s current ratio?

Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s current ratio has grown at a 3.3% compound annual growth rate (CAGR), from 6.9× to 8.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.